Immuron (IMRN) Gross Profit (2016 - 2024)

Immuron (IMRN) recorded quarterly Gross Profit of -$1737594727.2 billion in Q4 2024, down 109950132958505.31% quarter-over-quarter from $1.6 million in Q4 2023, and down 109950132958505.31% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Gross Profit (2016 - 2024) Analysis & Trends

Immuron's Gross Profit history runs 9 years deep, the most recent figure standing at -$1737594727.2 billion for Q4 2024.

  • In Q4 2024, Gross Profit fell 109950132958505.31% year-over-year to -$1737594727.2 billion; the TTM figure through Dec 2024 stood at -$1737594727.2 billion (down 83615319075966.94% YoY), while the FY2025 annual figure was $3.1 million, up 41.12% from the prior year.
  • Gross Profit was -$1737594727.2 billion for Q4 2024 at Immuron, down from $1.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.6 million in Q4 2023 to a low of -$1737594727.2 billion in Q4 2024.
  • Historically, Gross Profit has averaged -$289599121.2 billion across 5 years, with a median of $37175.4 in 2020.
  • The sharpest annual moves came in 2022 and 2024: Gross Profit surged 36086.56% in 2022, then sank 109950132958505.31% in 2024.
  • A 5-year view of Gross Profit shows it stood at $5719.6 in 2020, then slumped by 79.32% to $1182.5 in 2021, then soared by 36086.56% to $427920.0 in 2022, then surged by 269.31% to $1.6 million in 2023, then tumbled by 109950132958505.31% to -$1737594727.2 billion in 2024.
  • The last three Gross Profit figures came in at -$1737594727.2 billion (Q4 2024), $1.6 million (Q4 2023), and $68631.3 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immuron 921.61 Mn 921.58 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1,737,594,727.21 Bn
Dec 31, 2024 -1,737,594,727.21 Bn
Dec 31, 2023 1.58 Mn
Dec 31, 2023 1.58 Mn
Jun 30, 2023 68,631.26
Jun 30, 2023 68,631.26
Dec 31, 2022 427,920.00
Dec 31, 2022 427,920.00
Dec 31, 2021 1,182.54
Dec 31, 2021 1,182.54
Dec 31, 2020 5,719.56
Dec 31, 2020 5,719.56
Dec 31, 2019 11,214.25
Dec 31, 2019 11,214.25
Dec 31, 2018 746,754.00
Dec 31, 2018 746,754.00
Dec 31, 2017 564,074.12
Dec 31, 2017 564,074.12
Dec 31, 2016 361,687.03
Dec 31, 2016 361,687.03